Canadian singer Celine Dion was seen at the 2024 Grammy Awards amid her ongoing health issues. The pop icon and five-time Grammy winner was there at the annual awards to present Album of the Year, an accolade she had received 27 years ago. Celine was diagnosed with a neurological disorder stiff person syndrome (SPS) in 2022.
Celine was greeted by a standing ovation from the crowd while she walked on the stage to present the award to Taylor Swift. "Thank you all, I love you right back. When I say that I'm happy to be here, I really mean it from my heart," she said.
In late 2022, the 'My Heart Will Go On' singer first revealed to fans that she had been with a rare neurological disease that can cause debilitating muscle spasms. She revealed her health condition in a moving video which she posted on social media platform Instagram. She had postponed her tour dates, then.
What is Stiff Person Syndrome?
Stiff Person Syndrome (SPS) is a rare neurological disorder characterized by severe and progressive muscle stiffness and spasms, leading to significant disability and impairment in movement. Individuals with SPS experience involuntary muscle contractions that can cause rigidity and stiffness in various parts of the body, often resembling a "stiffening" or "locking" sensation.
The exact cause behind this disease involves an autoimmune response targeting the central nervous system, particularly the brain and spinal cord. Autoantibodies directed against proteins involved in neurotransmission, such as glutamic acid decarboxylase (GAD), are commonly found in individuals with SPS.
Symptoms of SPS can vary in severity and may include muscle stiffness, spasms, rigidity, and pain, typically affecting the trunk and limbs. These symptoms can be triggered or exacerbated by emotional stress, physical exertion, or sudden movements. Additionally, individuals with SPS may experience anxiety, depression, and other psychiatric symptoms due to the chronic and debilitating nature of the condition.
Treatment for SPS aims to alleviate symptoms and improve quality of life through a combination of medications, physical therapy, and supportive care. Immunosuppressive therapies, such as intravenous immunoglobulin (IVIG) or corticosteroids, may be prescribed to modulate the autoimmune response and reduce muscle stiffness. However, management of SPS can be challenging, and the condition may require lifelong monitoring and treatment to control symptoms and prevent complications.
